Plasma neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease: Findings from the PREVEND prospective cohort study

Setor K. Kunutsor*, José L. Flores-Guerrero, Lyanne M. Kieneker, Tom Nilsen, Clara Hidden, Erling Sundrehagen, Samuel Seidu, Robin P.F. Dullaart, Stephan J.L. Bakker

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

2 Citations (Scopus)
165 Downloads (Pure)

Abstract

Background: Neutrophil gelatinase-associated lipocalin (NGAL), a novel biomarker of acute kidney injury, might play a role in the development of atherosclerotic cardiovascular disease (CVD). We aimed to assess the association of circulating NGAL with CVD risk.

Materials and methods: Plasma NGAL concentrations were measured at baseline in 5275 participants in the PREVEND prospective study. Hazard ratios (95% confidence intervals [CI]) for CVD were estimated.

Results: After a median follow-up of 8.3 years, 338 participants developed first CVD events. Plasma NGAL was weakly to moderately correlated with several CVD risk markers. There was a non-linear relationship between NGAL and CVD risk. In analyses adjusted for established risk factors, the hazard ratio (95% CI) for CVD in a comparison of the top quartile versus bottom quartiles 1–2 of NGAL values was 1.35 (1.05–1.75; P = 0.022), which was abrogated after additional adjustment for other potential confounders (mainly attributed to high sensitivity C-reactive protein) 1.20 (0.92–1.57; P = 0.176). The association was considerably attenuated following further adjustment for renal function 1.05 (0.79–1.40; P = 0.745). The association between NGAL and CVD risk did not vary importantly in relevant clinical subgroups.

Conclusion: Evidence suggests a non-linear association between NGAL and CVD risk, which is dependent on inflammation and renal function.

Original languageEnglish
Pages (from-to)66-75
Number of pages10
JournalClinica Chimica Acta
Volume486
Early online date20 Jul 2018
DOIs
Publication statusPublished - 1 Nov 2018

Keywords

  • Cardiovascular disease
  • Cohort study
  • Neutrophil gelatinase-associated lipocalin
  • Risk factor

Fingerprint Dive into the research topics of 'Plasma neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease: Findings from the PREVEND prospective cohort study'. Together they form a unique fingerprint.

Cite this